These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 17200425)

  • 1. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus.
    Phillips S; MacDougall C; Holdford DA
    Ann Pharmacother; 2007 Jan; 41(1):13-20. PubMed ID: 17200425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
    Grim SA; Rapp RP; Martin CA; Evans ME
    Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of linezolid and vancomycin in the treatment of surgical site infections.
    Patanwala AE; Erstad BL; Nix DE
    Curr Med Res Opin; 2007 Jan; 23(1):185-93. PubMed ID: 17257479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empiric outpatient therapy with trimethoprim-sulfamethoxazole, cephalexin, or clindamycin for cellulitis.
    Khawcharoenporn T; Tice A
    Am J Med; 2010 Oct; 123(10):942-50. PubMed ID: 20920697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral antibiotic treatment for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: review of the literature.
    Khawcharoenporn T; Alan T
    Hawaii Med J; 2006 Oct; 65(10):290-3. PubMed ID: 17194061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model.
    Bounthavong M; Hsu DI; Okamoto MP
    Int J Clin Pract; 2009 Mar; 63(3):376-86. PubMed ID: 19222624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
    De Cock E; Sorensen S; Levrat F; Besnier JM; Dupon M; Guery B; Duttagupta S
    Med Mal Infect; 2009 May; 39(5):330-40. PubMed ID: 19304423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation.
    Miller LG; Perdreau-Remington F; Bayer AS; Diep B; Tan N; Bharadwa K; Tsui J; Perlroth J; Shay A; Tagudar G; Ibebuogu U; Spellberg B
    Clin Infect Dis; 2007 Feb; 44(4):471-82. PubMed ID: 17243048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
    Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and therapeutic evaluation of community-acquired methicillin-resistant Staphylococcus Aureus (MRSA) skin and soft tissue infections in the emergency department.
    Walraven CJ; Lingenfelter E; Rollo J; Madsen T; Alexander DP
    J Emerg Med; 2012 Apr; 42(4):392-9. PubMed ID: 21524884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA; Elston D; Akinlade BK; Weber K; Notario GF; Busman TA; Cifaldi M; Nilius AM
    Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
    Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
    Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.
    Ruhe JJ; Smith N; Bradsher RW; Menon A
    Clin Infect Dis; 2007 Mar; 44(6):777-84. PubMed ID: 17304447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral beta-lactams applied to uncomplicated infections of skin and skin structures.
    Jacobs MR; Jones RN; Giordano PA
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):55S-65S. PubMed ID: 17292581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of community-acquired methicillin-resistant Staphylococcus aureus in a private dermatology office.
    Bruce AM; Spencer JM
    J Drugs Dermatol; 2008 Aug; 7(8):751-5. PubMed ID: 18720691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic-resistant Staphylococcus aureus in community-acquired pediatric neck abscesses.
    Guss J; Kazahaya K
    Int J Pediatr Otorhinolaryngol; 2007 Jun; 71(6):943-8. PubMed ID: 17418426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No decrease in clindamycin susceptibility despite increased use of clindamycin for pediatric community-associated methicillin-resistant Staphylococcus aureus skin infections.
    Szczesiul JM; Shermock KM; Murtaza UI; Siberry GK
    Pediatr Infect Dis J; 2007 Sep; 26(9):852-4. PubMed ID: 17721387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children.
    Le J; Lieberman JM
    Pharmacotherapy; 2006 Dec; 26(12):1758-70. PubMed ID: 17125437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.